Related references
Note: Only part of the references are listed.Identification of Glycochenodeoxycholate 3-O-glucuronide and Glycodeoxycholate 3-O-glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers
Mikko Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Rotor Syndrome: Glucuronidated Bile Acidemia From Defective Reuptake by Hepatocytes
Akihiko Kimura et al.
HEPATOLOGY COMMUNICATIONS (2021)
Changes in conjugated urinary bile acids across age groups
Keiko Sato et al.
STEROIDS (2020)
Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver
Deepak Kumar Bhatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Species differences in bile acids I. Plasma and urine bile acid composition
Rhishikesh Thakare et al.
JOURNAL OF APPLIED TOXICOLOGY (2018)
Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions
Martin Perreault et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)
Kathleen M. Knights et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate
J. Trottier et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Developmental aspects of human hepatic drug glucuronidation in young children and adults
CP Strassburg et al.
GUT (2002)